Leadership Overview
Caidya has 5 executives leading key functions including strategy, technology, operations, legal, and medical affairs.
Driven by delivery excellence, Caidya offers a comprehensive suite of clinical services and deep therapeutic expertise, supporting global partners from early-stage strategy through post-marketing surveillance with industry-leading technology for transparent, data-driven decision-making.
Driven by delivery excellence, Caidya offers a comprehensive suite of clinical services and deep therapeutic expertise, supporting global partners from early-stage strategy through post-marketing surveillance with industry-leading technology for transparent, data-driven decision-making.
Leadership Roles at Caidya
Barbara Kunz - Chief Executive Officer
Barbara Kunz, the Chief Executive Officer at Caidya, directs the overarching corporate strategy and operational execution. Kunz guides the organization's mission to serve innovators worldwide, ensuring delivery excellence and an elevated customer experience across all clinical services. This leadership role involves setting the strategic vision for Caidya's vast therapeutic expertise, from pre-IND strategy through clinical development to submission and post-marketing surveillance. Barbara Kunz champions the integration of industry-leading and proprietary clinical technology, driving trial transparency and data-driven decision-making to support partners effectively. The Chief Executive Officer's focus remains on fostering innovation and maintaining Caidya's position as a premier multi-therapeutic clinical research organization.
Holly Guile - Chief of Staff & Chief Executive Officer, Office
Holly Guile, the Chief of Staff & Chief Executive Officer, Office at Caidya, optimizes internal operations and strategic alignment across departments. Guile ensures seamless execution of the company's mission, facilitating communication and collaboration between executive leadership and functional teams. This role is critical for maintaining Caidya's commitment to delivery excellence and an elevated customer experience, supporting the organization's broad range of clinical services and therapeutic expertise. Holly Guile's responsibilities include streamlining processes and enhancing operational efficiency to support partners from pre-IND strategy through clinical development to submission and post-marketing surveillance. The Chief of Staff function ensures that strategic initiatives are effectively implemented, contributing to Caidya's overall market impact and partner satisfaction.
John Scott - Senior VP, Information Technology & Chief Information Officer, Clinical Research Organization & Chief Revenue Officer
John Scott, the Senior VP, Information Technology & Chief Information Officer, Clinical Research Organization & Chief Revenue Officer at Caidya, architects the technological infrastructure and drives revenue generation strategies. Scott oversees the development and implementation of industry-leading and proprietary clinical technology, ensuring trial transparency and enabling data-driven decision-making across all projects. This dual role demands a comprehensive understanding of both IT operations and market dynamics, crucial for supporting Caidya's partners from pre-IND strategy through clinical development to submission and post-marketing surveillance. John Scott's leadership ensures that technological advancements directly translate into enhanced customer experience and delivery excellence. The Chief Revenue Officer function focuses on expanding market reach and optimizing sales processes to support Caidya's global growth objectives.
David Rifkind - Chief Legal Officer
David Rifkind, the Chief Legal Officer at Caidya, provides strategic counsel and ensures regulatory compliance across all operations. Rifkind oversees the legal framework supporting Caidya's multi-therapeutic clinical research services, safeguarding the company and its partners throughout the clinical development lifecycle. This critical role ensures adherence to global regulatory standards, from pre-IND strategy through clinical development to submission and post-marketing surveillance. David Rifkind's expertise is vital in navigating complex legal landscapes, protecting intellectual property, and managing contractual agreements that underpin Caidya's commitment to delivery excellence. The Chief Legal Officer's guidance is essential for maintaining trust and integrity in all partner engagements and business dealings.
Sharon Moore - Chief Medical Officer
Sharon Moore, the Chief Medical Officer at Caidya, directs the clinical strategy and medical oversight for all research initiatives. Moore ensures the scientific integrity and therapeutic relevance of Caidya's services, leveraging vast therapeutic expertise to support partners worldwide. This leadership position is fundamental to guiding clinical development from pre-IND strategy through submission and post-marketing surveillance, upholding the highest standards of patient safety and data quality. Sharon Moore's medical acumen is crucial for interpreting trial data and advising on optimal clinical pathways, reinforcing Caidya's commitment to delivery excellence and an elevated customer experience. The Chief Medical Officer's insights drive innovation in clinical trial design and execution.
Explore Leadership Teams in Business Services
NCI is attempting to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families, through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers.
Company Leadership SJ
DK
GT
AL
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics is headquartered in Fort Myers, Florida.
Company Leadership DO
MB
DL
LGC is a life sciences measurement and testing company providing laboratory services, reference materials, analytical testing products and services along with genomics solutions for the pharmaceutical, food, agricultural biotechnology, government, sports, and academia industries. The company was founded in 1996 and is headquartered in Middlesex, United Kingdom.
Company Leadership MM
ND
EK
Axens is a worldwide group that provides a complete range of solutions for the conversion of oil and biomass to cleaner fuels, for the production and purification of major petrochemical intermediates as well as for gas treatment and conversion options. The company was established in 2001 and is headquartered out of France.
Company Leadership BN
CS
FK
Frequently Asked Questions Regarding Caidya Top Executives and Leadership Team
